Liverpool Bio-Innovation Hub (LBIH) Biobank



Biobanking within the University of Liverpool is under new management and open for business, the LBIH Biobank now comes under the same management as the LUB. Both biobanks continue to offer a range of services, including the hosting of collections, sample collection services, access to archival collections and LIMS management. In addition, we can provide a range of histology services for formalin fixed and cryo-preserved tissue. A full list of our facilities is listed here.

Our services are flexible and tailored to individual customers/project requirements. For further information please contact the Biobank Manager, Sue Holden


We are delighted to announce that Professor Christian Ottensmeier has been appointed the Biobanking Academic Lead for the Faculty of Health and Life Sciences, taking over from Professor Ana Alfirevic. Professor Ottensmeier is an internationally-recognised experimental cancer researcher and Chair of Immuno-Oncology. His research, with a focus on immuno-oncology in head and neck and lung cancer, necessitates the use of highly-annotated clinical samples that have been collected, processed and stored under stringent protocols.

Professor Ottensmeier said “I am excited to be leading this new stage of the Faculty’s biobanking activity. I will use my experience of biobanking and working with tissue and sample collections to support the strategic aims and operational activities of the biobank team, Our aim is to develop an accessible repository of high-quality material with   detailed clinical annotations to enable high resolution analytical activity that ultimately supports academic endeavour at UoL”.

Dr Neil French, Head of Clinical Operations for the Clinical Directorate said “Christian’s commitment to and experience of high-quality biobanking solutions ensures that the academic leadership for biobanking at UoL remains in good hands. The team and I are looking forward to working with him as we build on the strong foundations of LUB and the LBIH Biobank".


We are delighted to announce, for the second year in a row, the LBIH Biobank has been shortlisted for the 2017 Bionow Technical Service Award - Sponsored by Gateley plc 

The prestigious awards, recognising the excellence, enterprise and endeavour of the North’s life sciences sector, are sponsored by Manchester Science Partnerships, the UK’s largest science and technology park operator. 
The event showcases the strength, depth and talent of businesses and individuals based in the North and recognises best in class achievement across 10 categories. Winners will be announced at the annual Bionow Awards, which take place on November 30th.


We have just found out that we are one of three biobanks to have been shortlisted for the prestigious UK Biobank of the Year 2017.

The UKCRC Tissue Directory and Coordination Centre is dedicated to supporting and promoting those who provide researchers with fit-for-purpose samples and data in the UK. The Biobank of the Year Award recognises the sterling work of human tissue resources in biobanking and seeks to recognise the one that has supported significant research output.


We are delighted to announce that the LBIH Biobank has been shortlisted for the 2016 Bionow Technical Service Award - Sponsored by Appleyard Lees.  

The prestigious awards, recognising the excellence, enterprise and endeavour of the North’s life sciences sector, are sponsored by Manchester Science Partnerships, the UK’s largest science and technology park operator. 

The event showcases the strength, depth and talent of businesses and individuals based in the North and recognises best in class achievement across 10 categories. Winners will be announced at the annual Bionow Awards, which take place on November 24.


A pre-Christmas event has been planned to celebrate the launch of the LBIH Biobank. Come along and help us celebrate our launch!

Date: Friday 4th December 2015.
Time: 6.00 - 9.00 pm

Venue: Foresight Centre, University of Liverpool. Building 359 on campus map

There will be several informative talks, presentations and tours of the new facility and of course some festive fare including mince pies and mulled wine. Please register for the event here.


Image of lise jacqueroux

Ms Lise Jacqueroux has spent the last 3 months at the LTB as part of her ‘Management of Biobanks’ Masters degree, which she's undertaking in France. During her internship at the LTB, Lise has learned about the day-to-day running of the LTB. She has also acquired practical experience in a range of skills, such as cutting formalin fixed paraffin embedded (FFPE) sections, staining slides with conventional stains (e.g. Haematoxylin and Eosin), peforming laser capture microdissection, as well as constructing tissue microarrays (TMA) from FPPE tumour blocks.

The LTB team wishes Lise all the best for the remainder of her studies. The LTB team looks forward to hosting several other local and international students, for internships and 'work experience' placements throughout the coming year.


A special symposium has been held to celebrate the 20th anniversary of the Liverpool Tissue Bank, which contains over 45,000 samples used by scientists, predominantly to study cancer. The Liverpool Tissue Bank was established at the University in 1993, following a donation of nearly £2.2 million from the Candis Club.

LTB Anniversary

Pictured: Professor Sarah Coupland, LTB Director; Professor Philip Rudland, who was involved with the opening of the LTB and Bob Hyatt, Candis Club Chairman.

The resource centre collects samples from a wide variety of tissue types, including breast, colon and pancreas cancers as well as rare tumours such as ocular melanomas, donated by consenting patients who have undergone surgery for cancer.

Professor Sarah Coupland, Liverpool Tissue Bank Director said: “The Liverpool Tissue Bank was the UK's first cancer bank; it showed tremendous foresight to collect tissue in a coordinated manner and to make sure that the quality of the specimens was excellent, so all sorts of research can be performed.” The LTB belong to the Confederation of Cancer Biobanks, and representatives from the CCB were also present at the symposium. Similarly, Mr Bob Hyatt, Chariman of Candis magazine, as well senior representatives from both RedX Oncology and Roy Castle Lung Cancer Research came to the event. The meeting was well attended in the CRC and received excellent feedback.

Liverpool Tissue Bank 20th Anniversary Celebration Programme


Introduction and Welcome - Prof Andrew Pettitt, Head of Department for Molecular and Clinical Cancer Medicine.

Historical Overview - Historical Overview Prof Sarah Coupland, Director of Liverpool Tissue Bank.

Confederation of Cancer Biobanks (CCB) - Dr Bridget Wilkins, NCRI Pathology Lead for NHS Engagement in Biobanking.

Liverpool Ocular Oncology Biobank - Dr Helen Kalirai.

Liverpool Lung Project - Dr Michael Davies.

Biobanking of Pancreas Tissue - Dr Eithne Costello.

Clinical Trials and GCLP - Dr William Greenhalf.

Lymphoma / Leukaemia Biobanks - Dr Melanie Oates.

Partnering with the NHS - Biobanking and Breast Cancer Research - Prof Christopher Holcombe.

Future and Vision of Biobanking - Prof Carlo Palmieri.


A feature of the Liverpool Tissue Bank 20th Anniversary was also was published on the Candis website.

29th July 2013


Redx Oncology has entered into an agreement with the University of Liverpool and the Royal Liverpool and Broadgreen University Hospitals Trust (RLBUHT) to provide valuable support to the Liverpool Tissue Bank (LTB).

The leading cancer R&D centre, which is a division of Liverpool drug discovery company Redx Pharma, will provide staff to help with the day-to-day running of the LTB.

Redx Oncology is a private company, which develops novel anti-cancer drugs, and was launched in April last year. It is based at laboratories within the Royal Liverpool University Hospital.

The LTB is a University of Liverpool and RLBUHT resource, where samples from consented patients with cancer are collected. These samples are banked to provide an invaluable resource for research groups investigating how cancers arise and developing new treatments to treat cancer, with the aim of improving patient survival.  

Redx staff will help analyse and capture data from these tissue samples at the LTB, providing valuable support for LTB staff. Scientific data generated will also be used to progress Redx Oncology’s on-going work to develop novel anti-cancer drugs.

Dr Mary-Ann Campbell, Head of Biology at Redx Oncology, said: “We’re delighted to be supporting the important work which the LTB enables. The tissue bank is a great resource, which allows us to analyse cancer cells in their most realistic or ‘active’ form –helping us to work on developing drugs, which can more accurately target and defeat this incredibly complex disease.”

Dr Neil Murray, CEO of Redx Pharma, said: “By providing our staff to support the LTB, we hope to help the LTB team with the day-to-day running of this fantastic facility, to the benefit of all involved. We already work very closely with the University, the CRUK Centre and the Royal in our fight against cancer and this agreement extends those links.

“The pharmaceutical industry is rapidly adopting a more collaborative model of R&D. Through partnerships of this nature, we’re positioning Redx at the forefront of this game-changing model, which sees businesses working in tandem with leading academics and clinicians to create the most efficient, effective and sustainable solutions for the ultimate benefit of patients.”

Prof. Sarah Coupland, Director of the LTB, said: “I am very pleased that Redx is willing to collaborate with the LTB, which is one of the oldest Tissue Banks in the UK. The LTB is celebrating its 20th anniversary in November this year in the CRUK Liverpool Centre. The support of Redx will guarantee that this essential work, in tissue and data collection continues long term according to national standards, and that researchers have the opportunity to access invaluable material, donated generously by cancer patients. This collaborative effort is all being undertaken with the aim of improving cancer patient care and survival, and I sincerely hope we can achieve this sooner rather than later.”

Prof Chris Holcombe, Cancer Lead at the Royal said: “The cancer specialists at the Royal Liverpool University Hospital are delighted with this collaboration with Redx and Liverpool University, and most importantly the precious resource of tissue donated by our patients will be even more effectively used, as we search for even better cancer treatments.”